Rahul Deshmukh
Rahul Deshmukh
Central University of Punjab
Verified email at
Cited by
Cited by
Excitotoxicity: bridge to various triggers in neurodegenerative disorders
A Mehta, M Prabhakar, P Kumar, R Deshmukh, PL Sharma
European journal of pharmacology 698 (1-3), 6-18, 2013
Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
D Kaur, V Sharma, R Deshmukh
Inflammopharmacology 27, 663-677, 2019
Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor
R Deshmukh, V Sharma, S Mehan, N Sharma, KL Bedi
European journal of pharmacology 620 (1-3), 49-56, 2009
Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease
K Kumar, A Kumar, RM Keegan, R Deshmukh
Biomedicine & pharmacotherapy 98, 297-307, 2018
Therapeutic potential of GABAB receptor ligands in drug addiction, anxiety, depression and other CNS disorders
K Kumar, S Sharma, P Kumar, R Deshmukh
Pharmacology Biochemistry and Behavior 110, 174-184, 2013
Neuroinflammation-A major cause for striatal dopaminergic degeneration in Parkinson's disease
K Kaur, JS Gill, PK Bansal, R Deshmukh
Journal of the neurological sciences 381, 308-314, 2017
Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats
R Deshmukh, M Kaundal, V Bansal
Biomedicine & Pharmacotherapy 81, 56-62, 2016
Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats
S Sharma, P Kumar, R Deshmukh
Neurochemistry International 116, 104-111, 2018
Tetrabenazine: spotlight on drug review
N Kaur, P Kumar, S Jamwal, R Deshmukh, V Gauttam
Annals of neurosciences 23 (3), 176-185, 2016
Alzheimer's disease: Is this a brain specific diabetic condition?
V Rani, R Deshmukh, P Jaswal, P Kumar, J Bariwal
Physiology & behavior 164, 259-267, 2016
Animal models of hepatotoxicity
GS Bhakuni, O Bedi, J Bariwal, R Deshmukh, P Kumar
Inflammation Research 65, 13-24, 2016
Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies
S Sharma, S Singh, V Sharma, VP Singh, R Deshmukh
Biomedicine & Pharmacotherapy 70, 283-293, 2015
Effect of GLT-1 modulator and P2X7 antagonists alone and in combination in the kindling model of epilepsy in rats
N Soni, P Koushal, BVK Reddy, R Deshmukh, P Kumar
Epilepsy & Behavior 48, 4-14, 2015
Phosphodiesterases: regulators of cyclic nucleotide signals and novel molecular target for movement disorders
S Sharma, K Kumar, R Deshmukh, PL Sharma
European journal of pharmacology 714 (1-3), 486-497, 2013
Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats
S Sharma, R Deshmukh
Neuroscience 286, 393-403, 2015
Attenuating effect of standardized lyophilized Cinnamomum zeylanicum bark extract against streptozotocin-induced experimental dementia of Alzheimer’s type
J Malik, K Munjal, R Deshmukh
Journal of basic and clinical physiology and pharmacology 26 (3), 275-285, 2015
Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation
S Datta, S Jamwal, R Deshmukh, P Kumar
European Journal of Pharmacology 771, 229-235, 2016
Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats
V Sharma, A Bala, R Deshmukh, KL Bedi, PL Sharma
Pharmacology Biochemistry and Behavior 101 (2), 239-245, 2012
Embelin attenuates intracerebroventricular streptozotocin-induced behavioral, biochemical, and neurochemical abnormalities in rats
R Arora, R Deshmukh
Molecular neurobiology 54 (9), 6670-6680, 2017
SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats
N Sharma, R Deshmukh, KL Bedi
Pharmacology Biochemistry and Behavior 96 (4), 386-394, 2010
The system can't perform the operation now. Try again later.
Articles 1–20